Viatris no bargain despite being cheapest S&P 500 stock, Barron’s says

Viatris is the cheapest stock in the S&P 500, trading at just 3.3-times earnings, with a dividend yield of 5.1%, Jack Hough writes in this week’s edition of Barron’s. This year, the company is likely to generate more than 20% of its stock market value in free cash. Yet only three of 11 analysts who cover the stock recommend buying it. Think carefully before doing so, the author says. Jefferies upgraded the stock in January, predicting a 29% rise. But so far it has gotten a 20% slide, the publication notes. Viatris used to be called Mylan, widely known for buying EpiPen and then jacking up the price per two-pack from about $100 to $600 between 2007 and 2016, says Hough.